RVTY: second_quarter 2026 lobbying report

{"url":"https://lda.gov/api/v1/filings/e89ae40d-6d5c-45a3-9fc7-47a1d807bbc6/","filing_uuid":"e89ae40d-6d5c-45a3-9fc7-47a1d807bbc6","filing_type":"Q2","filing_type_display":"2nd Quarter - Report","filing_year":2026,"filing_period":"second_quarter","filing_period_display":"2nd Quarter (Apr 1 - June 30)","filing_document_url":"https://lda.gov/filings/public/filing/e89ae40d-6d5c-45a3-9fc7-47a1d807bbc6/print/","filing_document_content_type":"text/html","income":null,"expenses":"40000.00","expenses_method":"A","expenses_method_display":"A","posted_by_name":"Luis M. Tovar","dt_posted":"2026-07-13T11:29:07-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"77 4th Avenue","registrant_address_2":null,"registrant_different_address":false,"registrant_city":"Waltham","registrant_state":"MA","registrant_zip":"02451","registrant":{"id":401105953,"url":"https://lda.gov/api/v1/registrants/401105953/","house_registrant_id":null,"name":"REVVITY, INC.","description":"Provides products and services for Life Sciences/Diagnostics.","address_1":"77 4th Avenue","address_2":null,"address_3":null,"address_4":null,"city":"Waltham","state":"MA","state_display":"Massachusetts","zip":"02451","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"LUIS M. TOVAR","contact_telephone":"+1 774-422-9041","dt_updated":"2026-07-10T13:42:56.425475-04:00"},"client":{"id":208897,"url":"https://lda.gov/api/v1/clients/208897/","client_id":12,"name":"REVVITY, INC.","general_description":null,"client_government_entity":false,"client_self_select":true,"state":"MA","state_display":"Massachusetts","country":"US","country_display":"United States of America","ppb_state":"MA","ppb_state_display":"Massachusetts","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2021-03-17"},"lobbying_activities":[{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"Diagnostic test reimbursement and policies Proposals related to newborn screening HR 4709 - Newborn Screening Saves Lives Act Reauthorization Act of 2025 H.R. 2810, Family Cord Blood Banking Act S. 4612 SCREEN for Type 1 Diabetes Act Newborn Screening Amendment to NDAA","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":149946,"prefix":null,"prefix_display":null,"first_name":"LUIS","nickname":null,"middle_name":"M.","last_name":"TOVAR","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]}